United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2006_register
executive
2010-09-22
article
Determination of Regulatory Review Period for Purposes of Patent Extension; ALAMAST
Notices
D09002ee1bde20d27
D09002ee1bde20d8d
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
Food and Drug Administration
originator
org
United States Government Agency or Subagency
The Food and Drug Administration (FDA) has determined the regulatory review period for ALAMAST and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of Patents and Trademarks, Department of Commerce, for the extension of a patent that claims that human drug product.
71 FR 14707
https://www.govinfo.gov/app/details/FR-2006-03-23/E6-4163
E6-4163
fr23mr06-45
4160-01-S
Docket No. 2000E-1252
https://www.govinfo.gov/app/details/FR-2006-03-23/E6-4163
https://www.govinfo.gov/content/pkg/FR-2006-03-23/html/E6-4163.htm
https://www.govinfo.gov/content/pkg/FR-2006-03-23/pdf/E6-4163.pdf
2 p.
14707
14708
71 FR 14707
Determination of Regulatory Review Period for Purposes of Patent Extension; ALAMAST; Federal Register Vol. 71, Issue
NOTICE
E6-4163
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Docket No. 2000E-1252
4160-01-S
E6-4163
Notice.
The Food and Drug Administration (FDA) has determined the regulatory review period for ALAMAST and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of Patents and Trademarks, Department of Commerce, for the extension of a patent that claims that human drug product.
Claudia V. Grillo, Office of Regulatory Policy (HFD-013), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 240-453-6681.
Human drugs:
Patent extension; regulatory review period determinations
ALAMAST,
http://www.fda.gov/dockets/ecomments
Federal Register
Vol. 71, no. 56
Office of the Federal Register, National Archives and Records Administration
2006-03-23
continuing
daily
deposited
born digital
175 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2006-03-23
P0b002ee18095cad5
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr23mr06
https://www.govinfo.gov/app/details/FR-2006-03-23
https://www.govinfo.gov/content/pkg/FR-2006-03-23/pdf/FR-2006-03-23.pdf
https://www.govinfo.gov/content/pkg/FR-2006-03-23/xml/FR-2006-03-23.xml
fdlp
14629
14793
DGPO
2010-09-22
2023-05-03
FR-2006-03-23
machine generated
eng
FR
FR-2006-03-23
71
56